Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingtong Peng

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical Nuclear Medicine|September 3, 2025
Heterotopic Pancreas Mimicking Gastrointestinal Stromal Tumor on 68Ga-NOTA-RM26 PET/CTRongxi Wang, Xingtong Peng, Jiarou Wang, et al.
JCEM Case Reports|March 2, 2026
Successful Management of Ectopic Adrenocorticotropin-Secreting Thymic Carcinoid With Mitotane: A New Look at an Old DrugXiang Zhou, Yuan Xu, Xingtong Peng, et al.
Journal of Cellular and Molecular Medicine|January 31, 2025
An Occult Primary Thymic Mucosa-Associated Lymphoid Tissue Lymphoma With Sjögren's Syndrome Revealed by CXCR4 Targeted <sup>68</sup>Ga-Pentixafor PET/CTXuehan Gao, Xingtong Peng, Rongxi Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2025
Comparison of [<sup>68</sup>Ga]Ga-Fibroblast Activation Protein Inhibitor-04 and [<sup>18</sup>F]FDG PET Imaging for Solitary Fibrous Tumor and Preliminary Application of FAP-Targeted Radiopharmaceutical TherapyRongxi Wang, Jiarou Wang, Jialin Xiang, et al.
Theranostics|June 7, 2023
Dual targeting PET tracer [Rongxi Wang, Vivianne Jakobsson, Jiarou Wang, et al.
Molecular Pharmaceutics|December 17, 2025
Preclinical and Initial Clinical Evaluation of <sup>68</sup>Ga/<sup>177</sup>Lu-Labeled Heterodimer Agents Targeting Somatostatin Receptors and Integrin α<sub>V</sub>β<sub>3</sub>Linlin Li, Xingtong Peng, Jialin Xiang, et al.
Clinical Nuclear Medicine|April 6, 2026
Dual-targeted 68Ga-NOTA-3P-TATE-RGD PET/CT in Radioactive-iodine Negative Differentiated Thyroid Cancer: An Exploratory Comparative Study With 18F-FDGJialin Xiang, Yanwei Wang, Xin Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2024
Head-to-Head Comparison of [<sup>68</sup>Ga]Ga-NOTA-RM26 and [<sup>18</sup>F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective StudyRongxi Wang, Weiming Kang, Zhen Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 9, 2025
[<sup>68</sup>Ga]Ga-P16-093 PET/CT in newly diagnosed prostate cancer: Histopathological validation and comparison with [<sup>68</sup>Ga]Ga-PSMA-11Jiarou Wang, Linlin Li, Jingci Chen, et al.
ACS Pharmacology & Translational Science|October 17, 2024
Evaluation of Angiotensin-Converting Enzyme 2 Expression <i>In Vivo</i> with Novel <sup>68</sup>Ga-Labeled Peptides Originated from the Coronavirus Receptor-Binding DomainLinlin Li, Rongxi Wang, Li He, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Nuclear Medicine|September 3, 2025
Heterotopic Pancreas Mimicking Gastrointestinal Stromal Tumor on 68Ga-NOTA-RM26 PET/CTRongxi Wang, Xingtong Peng, Jiarou Wang, et al.
JCEM Case Reports|March 2, 2026
Successful Management of Ectopic Adrenocorticotropin-Secreting Thymic Carcinoid With Mitotane: A New Look at an Old DrugXiang Zhou, Yuan Xu, Xingtong Peng, et al.
Journal of Cellular and Molecular Medicine|January 31, 2025
An Occult Primary Thymic Mucosa-Associated Lymphoid Tissue Lymphoma With Sjögren's Syndrome Revealed by CXCR4 Targeted <sup>68</sup>Ga-Pentixafor PET/CTXuehan Gao, Xingtong Peng, Rongxi Wang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2025
Comparison of [<sup>68</sup>Ga]Ga-Fibroblast Activation Protein Inhibitor-04 and [<sup>18</sup>F]FDG PET Imaging for Solitary Fibrous Tumor and Preliminary Application of FAP-Targeted Radiopharmaceutical TherapyRongxi Wang, Jiarou Wang, Jialin Xiang, et al.
Theranostics|June 7, 2023
Dual targeting PET tracer [Rongxi Wang, Vivianne Jakobsson, Jiarou Wang, et al.
Molecular Pharmaceutics|December 17, 2025
Preclinical and Initial Clinical Evaluation of <sup>68</sup>Ga/<sup>177</sup>Lu-Labeled Heterodimer Agents Targeting Somatostatin Receptors and Integrin α<sub>V</sub>β<sub>3</sub>Linlin Li, Xingtong Peng, Jialin Xiang, et al.
Clinical Nuclear Medicine|April 6, 2026
Dual-targeted 68Ga-NOTA-3P-TATE-RGD PET/CT in Radioactive-iodine Negative Differentiated Thyroid Cancer: An Exploratory Comparative Study With 18F-FDGJialin Xiang, Yanwei Wang, Xin Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2024
Head-to-Head Comparison of [<sup>68</sup>Ga]Ga-NOTA-RM26 and [<sup>18</sup>F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective StudyRongxi Wang, Weiming Kang, Zhen Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 9, 2025
[<sup>68</sup>Ga]Ga-P16-093 PET/CT in newly diagnosed prostate cancer: Histopathological validation and comparison with [<sup>68</sup>Ga]Ga-PSMA-11Jiarou Wang, Linlin Li, Jingci Chen, et al.
ACS Pharmacology & Translational Science|October 17, 2024
Evaluation of Angiotensin-Converting Enzyme 2 Expression <i>In Vivo</i> with Novel <sup>68</sup>Ga-Labeled Peptides Originated from the Coronavirus Receptor-Binding DomainLinlin Li, Rongxi Wang, Li He, et al.
Pageof 2